PreciseDx
Ted M. Diehl, CMR has extensive experience in commercial development, particularly in the field of oncology. Ted M. has held leadership positions in companies such as PreciseDx, Massive Bio, Sema4, IBM, Genomic Health, Sanofi, and TAP Pharmaceuticals. Ted has a Master of Arts degree in Executive Leadership from Liberty University and Bachelor of Arts degrees in Organizational Leadership and Human Resources Management/Personnel Administration, General from Immaculata University. Ted M.'s expertise lies in developing commercial strategies, team leadership, alliance building, and advancing diagnostic AI technologies in oncology.
This person is not in any offices
PreciseDx
PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology features, enabling better and more personalized treatment and outcomes.